Citations for
1CD274, PDCD1, PDCD1LG2
Human PD-1 binds differently to its human ligands: a comprehensive modeling study.
Viricel C, Ahmed M, Barakat K.
J Mol Graph Model 57:131-42. doi: 10.1016/j.jmgm.2015.01.015. 2015
2CD274, PDCD1LG2
TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.
Beswick EJ, Johnson JR, Saada JI, Humen M, House J, Dann S, Qiu S, Brasier AR, Powell DW, Reyes VE, Pinchuk IV.
J Immunol 193(5):2218-29. doi: 10.4049/jimmunol.1203441. Epub 2014 Jul 28. 2014
3PDCD1LG2
PD-L2 is expressed on activated human T cells and regulates their function.
Messal N, Serriari NE, Pastor S, Nunès JA, Olive D.
Mol Immunol 48(15-16):2214-9. Epub 2011 Jul 12. 2011
4PDCD1LG2
The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells.
Du GH, Qin XP, Li Q, Zhou YM, Shen XM, Tang GY.
J Oral Pathol Med 40(7):525-32. doi: 10.1111/j.1600-0714.2011.01035.x. Epub 2011 Apr 2. 2011
5PDCD1LG2, POU2F1, POU2F2
Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.
Kaku H, Rothstein TL.
Genes Immun 11(1):55-66. Epub 2009 Aug 27. 2010
6CD274, PDCD1LG2
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
Ghiotto M, Gauthier L, Serriari N, Pastor S, Truneh A, Nunès JA, Olive D.
Int Immunol 22(8):651-60. Epub 2010 Jun 29. 2010
7PDCD1, PDCD1LG2
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
Yamamoto R, Nishikori M, Kitawaki T, Sakai T, Hishizawa M, Tashima M, Kondo T, Ohmori K, Kurata M, Hayashi T, Uchiyama T.
Blood 111(6):3220-4. Epub 2008 Jan 18. 2008
8PDCD1, PDCD1LG2, CD274
PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.
Ni R, Ihara K, Miyako K, Kuromaru R, Inuo M, Kohno H, Hara T.
Hum Genet 121(2):223-32. Epub 2007 Jan 3. 2007
9PDCD1, CD274 , PDCD1LG2
Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects.
Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, Gonzalez A.
Arthritis Rheum 50(8):2590-7. 2004
10PDCD1LG2
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells.
Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H.
J Exp Med 193(7):839-46. 2001
11PDCD1LG2
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y,Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL,Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, FreemanGJ.
Nat Immunol 2(3):261-8. 2001